Curcumin for Osteoarthritis

Verdict: Modest, real relief for knee OA pain

Curcumin (turmeric extract) has preliminary but reasonably consistent evidence that it eases knee osteoarthritis pain and lowers inflammatory markers, working on symptoms only — it does not repair cartilage or modify the disease, and a real liver-injury safety signal means it should be used cautiously.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

Three recent meta-analyses point the same way. A 2024 Bayesian network meta-analysis (PMID 38036015, n=2,175) found curcumin cut VAS pain (MD -1.63) and WOMAC total scores (MD -18.85) versus placebo, with fewer side effects than NSAIDs; a 2025 network meta-analysis (PMID 40731001, n=913) confirmed lower WOMAC pain across formulations; and a 2025 review (PMID 40615851, n=1,705) showed reduced CRP and TNF-alpha. Head-to-head RCTs (PMID 33516238, BCM-95; PMID 35010916, Curcugen) found it non-inferior to paracetamol with better tolerability.

It stays at B rather than A for honest reasons. The benefit is limited to symptoms: one RCT (PMID 32926799) improved pain but showed no change in MRI synovitis or cartilage, so curcumin is not a cartilage repair or disease-modifying treatment. Authors graded their own certainty as low to very low, sample sizes were small, and several key RCTs were industry-funded (PMID 35010916, PMID 32926799), inflating overstatement risk.

Authorities are split. NIH NCCIH says we don't yet know enough to confirm any benefit; Harvard Health is cautious; the rheumatology society's OA guideline (L5e) issues a conditional recommendation against it. Mayo and Cleveland Clinic are more supportive. EFSA set an ADI of 3 mg/kg/day but rejected joint-health claims, and NHS Wales warns against use in liver, gallstone, or bile-duct disease — reflecting documented liver-injury cases, especially with high-absorption, piperine-enhanced products.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.66
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
76%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.52
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.85
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.662
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (6)L2 · primary research & systematic reviews

Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis
PMID: 40731001 2025 Network Meta-analysis n = 913
Finding: All turmeric preparations significantly reduced WOMAC pain vs placebo: BE+AC MD -4.01 (95% CI -6.22 to -1.80); active comparator alone -3.33 (-5.26 to -1.39); conventional curcuminoid -3.17 (-5.50 to -0.83); bioavailability-enhanced -2.47 (-3.27 to -1.67); BE alone exceeded MCID by ~30%
Academic Effect size: [object Object]
View on PubMed
Effects of curcumin on serum inflammatory biomarkers in patients with knee osteoarthritis: a systematic review and meta-analysis of RCTs
PMID: 40615851 2025 統合分析 n = 1,705
Finding: Curcumin significantly lowered CRP (SMD -0.906, 95% CI -1.543 to -0.269, p=0.005) and TNF-alpha (SMD -0.921, 95% CI -1.817 to -0.026, p=0.044); ESR, IL-6, IL-1beta, PGE-2 not significant
🟢 High quality Academic Effect size: [object Object]
View on PubMed
Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis
PMID: 38036015 2024 Network Meta-analysis n = 2,175
Finding: vs placebo: VAS MD -1.63 (95% CI -2.91 to -0.45); WOMAC total MD -18.85 (-29.53 to -8.76); rescue-medication OR 0.17. vs NSAIDs: fewer adverse events with curcumin (OR 0.51) and curcumin+NSAIDs (OR 0.23)
🟢 High quality Effect size: [object Object]
View on PubMed
An Investigation into the Effects of a Curcumin Extract (Curcugen) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study
PMID: 35010916 2021 RCT (double-blind) n = 101
Finding: Curcugen significantly reduced KOOS pain vs placebo (p=0.009); numeric knee pain p=0.001; 37% of curcumin arm reduced rescue analgesics vs 13% placebo
⚠️ Industry-funded
View on PubMed
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis: A Randomized Trial
PMID: 32926799 2020 RCT (double-blind) n = 70
Finding: VAS pain reduced by -9.1 mm vs placebo (95% CI -17.8 to -0.4, p=0.039); WOMAC pain MD -47.2 mm (95% CI -81.2 to -13.2, p=0.006); no effect on MRI effusion-synovitis volume or cartilage composition
⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol
PMID: 33516238 2021 RCT (double-blind) n = 144
Finding: BCM-95 non-inferior to paracetamol on WOMAC pain (within 0.5 effect-size margin); BCM-95 reduced CRP -37.21% and TNF-alpha -74.81%; adverse events 5.48% (BCM-95) vs 12.68% (paracetamol)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4b EU EFSA
Cautious
the Panel established an ADI for curcumin of 3 mg/kg bw/day source↗
L4c UK NHS
Cautious
Avoid turmeric and curcumin in individuals with bile duct obstruction, cholangitis, liver disease, gallstones, or any biliary disease. source↗
L4d TW TFDA / 衛福部
Cautious
薑黃素每人每日攝取量為每公斤體重0~3毫克,每日不超過200毫克為宜 source↗
L4e WHO
Neutral
Rhizoma Curcumae Longae source↗
L5a NIH Office of Dietary Supplements
Cautious
We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes. source↗
L5b Mayo Clinic
Supportive
comparable to taking a 1,200-milligram dose of ibuprofen daily for arthritis pain source↗
L5c Cleveland Clinic
Supportive
Studies have also shown that turmeric may reduce joint inflammation and pain associated with osteoarthritis. source↗
L5d Harvard Health
Cautious
turmeric may help relieve symptoms of osteoarthritis source↗
L5e Specialty Society (condition-mapped)
Against
Current recommendation is to take curcumin, the active form of turmeric at 500 mg–1000 mg daily. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬6 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-osteoarthritis-INT-curcumin-001 繁體中文版 →